FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): PF-04554878
Approved:
Kinase Class: RY
Inhibitor Type: ?
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): protein tyrosine kinase 2
Disease(s): ovarian carcinoma

Defactinib hydrochloride US FDA Label

Compound: N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
Description: NA

International Nonproprietary Name: DEFACTINIB [INN] (Source: PubChem)

KEGG Drug ID: D10618 (Source: PubChem)

SureChEMBL ID: SCHEMBL1627234 (Source: PubChem)

USFDA Precision ID: UNII-53O87HA2QU (Source: PubChem)

US Adopted Name: Defactinib [USAN] (Source: PubChem)

Sources: PubChem (5)